Regeneron Pharmaceuticals Inc. buy TD Cowen
Summary
This prediction ended on 07.12.24 with a price of €742.40. With a performance of -4.94%, the BUY prediction by TD_Cowen finished with a loss. TD_Cowen has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -0.391% | -0.391% | -1.952% |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% |
Comments by TD_Cowen for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.
Stopped prediction by TD_Cowen for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
23.07.24
23.07.25
24.07.25
Regeneron Pharmaceuticals Inc.
24.04.24
24.04.25
25.04.25

